Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Financial Results

Set Alert for Financial Results

Latest From Financial Results

Virbac's Q4 and full year show around 1% sales growth

Virbac has reported 1% growth in the fourth quarter of 2018, as its international business overcame a lingering impact related to destocking issues in the US.

Virbac Financial Results

Dechra set for big H1 as acquisitions support 18% sales upturn

UK firm Dechra Pharmaceuticals is predicting around 18% growth during its fiscal first half of 2019.

Dechra Pharmaceuticals Financial Results

Bioveta secures more double-digit growth through vaccine sales

Czech Republic-based Bioveta maintained its recent double-digit sales growth into fiscal 2018.

Financial Results Vaccines

Elanco predicts growth improvement in 2019, restructuring to cut 200 jobs

Elanco has predicted sales growth next year, which could be the first time its annual revenues increase since 2015.

Elanco Operations

ECO growth stays strong in half-year, protects against Brexit with new subsidiary

UK firm ECO Animal Health posted a 9% increase in sales during the six months ended September 30, 2018.

Eco Animal Health Financial Results

Patterson Q2 highlights ongoing improvement in fiscal 2019

US distributor Patterson Companies' animal health business continued to maintain a healthy financial display into the second quarter of fiscal 2019.

Patterson Companies Financial Results
See All